In advance of International Women’s Day, Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), announced today that Covenant Health Fort Sanders Regional is the first hospital in Tennessee to use the Company’s S-Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the operating room.
“OCT technology enhances the level of care I am able to provide and has become a valuable tool in the operating room,” said Dr. Ana Wilson, a surgical oncologist with Covenant Health Fort Sanders Regional. “It allows me to make patient-specific surgical decisions in real-time and potentially reduce the likelihood of my patients returning for a second surgery.”
Traditional technologies such as X-ray, ultrasound or MRI don’t have the resolution to see disease at the cellular level. As a result, surgeons must wait up to 10 days for pathology results to either confirm clean margins or show positive margins, which often result in patients returning for another procedure.
“Being the first in Tennessee is another milestone in our continued expansion into new geographies nationwide,” said Perimeter Chief Financial Officer, Sara Brien. “Bringing our Perimeter S-Series OCT to Covenant Health Fort Sanders Regional also advances an important company goal of broadening access to our innovative technologies for margin visualization, in real-time, in the OR, to potentially improve outcomes and reduce healthcare costs.”
The S-Series OCT uses light to create cross-sectional 3D images of tissue microstructures at 10 times the resolution of ultrasound and X-ray and 100 times the power of magnetic resonance imaging (MRI). With the ability to see down to 2 mm in ducts, vessels and glands in the operating room, surgeons can get real-time clarity on margins, giving them the insight they need to help make the best surgical decisions for their patients and feel more confident in their outcomes.
“Perimeter is working tirelessly to help surgeons provide the best possible care for their patients,” said Suzanne Foster, Chairperson of Perimeter’s Board of Directors. Suzanne, as a breast cancer survivor, has a personal connection to Perimeter’s mission to transform cancer surgery, understanding the need for all patients to have access to advanced technology in hopes to improve surgical outcomes.
S-Series OCT Intended Use and Unapproved Uses
The S-Series OCT is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization with image review manipulation software for identifying and annotating regions of interest.
The S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established.
